Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025
-
ZoomInfo Announces Second Quarter 2025 Financial Results
-
Paymentus Reports Second Quarter 2025 Financial Results
-
MP Materials to Participate in Canaccord Genuity’s 45th Annual Growth Conference
-
Sabra Reports Second Quarter 2025 Results; Updates 2025 Guidance
-
Inseego Continues the Strategic Transformation of Its Business With Two Key Hires
-
TrueBlue Reports Second Quarter 2025 Results
-
Open Lending Announces Early Extension of AmTrust Producer Agreement
-
Better.com Selected as Finalist for the 2025 Finovate Awards
-
Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer
-
Armada Hoffler Reports Second Quarter 2025 Results
-
Myomo to Report Second Quarter 2025 Financial Results on August 11
-
Nasdaq Reports July 2025 Volumes
-
HEO and Satellogic Expand Agreement with Exclusive Access to Non-Earth Imagery for Space Domain Awareness
-
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
MercadoLibre Inc., Reports Second Quarter 2025 Financial Results
-
OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference
-
Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results
-
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
-
TEN Ltd. Announces the Order of Two VLCCs from Hanwha Ocean in South Korea and the Sale of Three 2007-Built Tankers
-
Castle Biosciences Reports Second Quarter 2025 Results
-
Inspirato to Announce Second Quarter 2025 Financial Results on Tuesday, August 12, 2025
-
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
-
Crane NXT to Participate in the Oppenheimer 28th Annual Technology, Internet & Communications Conference
-
Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement
-
ZoomInfo Appoints Graham O’Brien Chief Financial Officer
-
Weave Names Abhi Sharma as Chief Technology Officer
-
Ichor Announces CEO Succession Plan
-
Navitas Semiconductor Announces Second Quarter 2025 Financial Results
-
Letter to Stockholders Issued by Diamondback Energy, Inc
-
BioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance¹ for Total Revenues, Non-GAAP Operating Margin, and Non-GAAP Diluted EPS
-
Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025
-
Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook
-
Eaton Vance California Municipal Bond Fund and Eaton Vance New York Municipal Bond Fund Announce Liquidation Proposal
-
FibroGen to Report Second Quarter 2025 Financial Results
-
Diamondback Energy, Inc. Announces Second Quarter 2025 Financial and Operating Results
-
Currenc Group Inc. Announces Second Quarter and First Half 2025 Financial Results
-
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Reports Second Quarter 2025 Financial and Operating Results
-
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Semler Scientific® Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025
-
Axon reports Q2 2025 revenue of $669 million, up 33% year over year
-
VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering
-
Heidrick & Struggles Delivers 14% Revenue Growth in Q2, Driving Strong Profitability
-
ALLEGIANT TRAVEL COMPANY SECOND QUARTER 2025 FINANCIAL RESULTS
-
SBA Communications Corporation Reports Second Quarter 2025 Results; Updates Full Year 2025 Outlook; and Declares Quarterly Cash Dividend
-
Vertex Reports Second Quarter 2025 Financial Results
-
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
-
Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain
-
Dorman Products, Inc. Reports Second Quarter 2025 Results and Raises Full Year 2025 Guidance
-
Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update
